The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMacfarlane Grp. Regulatory News (MACF)

Share Price Information for Macfarlane Grp. (MACF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 143.00
Bid: 143.00
Ask: 145.50
Change: -1.50 (-1.04%)
Spread: 2.50 (1.748%)
Open: 145.00
High: 145.50
Low: 143.00
Prev. Close: 144.50
MACF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

19 May 2022 07:00

RNS Number : 0143M
Macfarlane Group PLC
19 May 2022
 
19 May 2022

 

Macfarlane Group PLC

Notification and public disclosure of transaction by PDMR

Macfarlane Group PLC (LON: MACF) announces that on 17 May 2022 the following persons discharging managerial responsibilities ('PDMRs') acquired ordinary shares of 25 pence each in the Company for nil consideration upon the maturity of 17 May 2019 awards under the Company's 2016 Performance Share Plan ("PSP") as summarised below together with details of the subsequent sales on 18 May 2022 automatically arranged on their behalf in accordance with the terms of the PSP to satisfy related tax and national insurance liabilities:

PDMR

 

Number of shares acquired for nil cost (including those added for in respect of dividend equivalent)

 

Number of shares sold to satisfy income tax and national insurance

Number of shares retained post sale

Peter Atkinson

 

349,517

168,642

180,875

Ivor Gray

 

60,630

29,860

30,770

In accordance with the terms of the awards the number of shares retained post sale are subject to a two year holding period.

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Peter Atkinson

2. Ivor Gray

 

2

Reason for Notification

a)

Position/status

1. Chief Executive

2. Group Finance Director

 

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Macfarlane Group PLC

b)

LEI

213800LVRYDERSJAAZ73

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 25 pence each in Macfarlane Group plc

GB0005518872

b)

Nature of the transaction

Settlement of conditional award under the Company acquired for nil consideration.

c)

Price(s) and volume(s)

 

 

 

 

Price(s)

Volume(s)

1. Nil

2. Nil

1. 349,517 ordinary shares

2. 60,630 ordinary shares

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable - single transactions

Nil

e)

Date of the transaction

17 May 2022

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Peter Atkinson

2. Ivor Gray

 

2

Reason for Notification

a)

Position/status

1. Chief Executive

2. Group Finance Director

 

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Macfarlane Group PLC

b)

LEI

213800LVRYDERSJAAZ73

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 25 pence each in Macfarlane Group plc

GB0005518872

b)

Nature of the transaction

Disposals arranged by the Company's employee benefit trust to cover income tax and national insurance liabilities

c)

Price(s) and volume(s)

 

 

 

 

Price(s)

Volume(s)

1. 1.17625

2.

2. . 1.17625

 

1. 168,642

2. 29,860

 

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable - single transactions

e)

Date of the transaction

18 May 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

Further enquiries:

Macfarlane Group

Tel: 0141 333 9666

Stuart Paterson Chairman

Peter Atkinson Chief Executive

Ivor Gray Finance Director

 

Spreng Thomson

Tel: 0141 548 5191

Callum Spreng

Mob: 07803 970103

 

Notes to Editors:

· Macfarlane Group PLC has been listed on the Premium segment of the Main Market of the London Stock Exchange (LSE: MACF) since 1973 with over 70 years' experience in the UK packaging industry.

· Through its two divisions Macfarlane Group services a broad range of business customers, supplying them high quality protective packaging which help customers reduce supply chain costs, improve their operational efficiencies and enhance their brand presentation. The divisions are:

Packaging Distribution - Macfarlane Packaging Distribution is the leading UK distributor of a comprehensive range of protective packaging products; and

Manufacturing Operations - Macfarlane Design and Manufacture who design and produce protective packaging for high value and fragile products.

· Headquartered in Glasgow, Scotland, Macfarlane Group employs over 1,000 people at 37 sites, principally in the UK, as well as in Germany, Ireland and the Netherlands.

· Macfarlane Group supplies more than 20,000 customers principally in the UK and Europe.

· In partnership with 1,700 suppliers, Macfarlane Group distributes and manufactures 600,000+ lines across a wide range of sectors, including: retail e-commerce; consumer goods; food; logistics; mail order; electronics; defence, automotive and aerospace.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBLGDUSSBDGDI
Date   Source Headline
25th Apr 202410:36 amRNSNotice of Annual General Meeting
11th Apr 20244:56 pmRNSHolding(s) in Company
8th Apr 20241:59 pmRNSHolding(s) in Company
3rd Apr 202411:15 amRNSHolding(s) in Company
28th Mar 20242:22 pmRNSDirector/PDMR Shareholding
28th Mar 202411:15 amRNSDirector / PDMR Shareholding & EBT share purchase
19th Mar 20247:00 amRNSIssue of Shares
15th Mar 20244:45 pmRNSHolding(s) in Company
13th Mar 20247:00 amRNSAcquisition of Allpack Packaging Supplies Limited
29th Feb 20247:00 amRNSAnnual Results 2023
26th Feb 20241:46 pmRNSInvestor Presentation via Investor Meet Company
14th Feb 202410:29 amRNSNotice of Results
13th Dec 202310:00 amRNSBoard Changes
23rd Nov 20237:00 amRNSTrading Update
31st Oct 20238:19 amRNSHolding(s) in Company
2nd Oct 20237:00 amRNSAcquisition of B&D 2010 Group Limited
29th Aug 20237:00 amRNSIssue of Shares
24th Aug 20237:00 amRNSHalf-year Report
8th Aug 20237:00 amRNSInvestor Presentation via Investor Meet Company
4th Aug 20237:00 amRNSNotice of Results
6th Jul 20231:29 pmRNSHolding(s) in Company
9th May 20233:08 pmRNSResult of AGM
9th May 20237:00 amRNSAGM Trading Update
2nd May 20237:00 amRNSAcquisition
28th Apr 20235:17 pmRNSNotice of AGM
20th Apr 20235:18 pmRNSHolding(s) in Company
20th Apr 20232:03 pmRNSHolding(s) in Company
31st Mar 20237:00 amRNSAnnual Report 2022
27th Mar 202312:29 pmRNSDirector/PDMR Shareholding
6th Mar 20237:00 amRNSAcquisition
23rd Feb 20237:00 amRNSAnnual Results 2022
15th Feb 20237:00 amRNSNotice of Results
29th Nov 20227:00 amRNSDirector/PDMR Shareholding
28th Nov 20227:00 amRNSDirector/PDMR Shareholding
24th Nov 20227:00 amRNSTrading Update
7th Oct 202210:00 amRNSHolding(s) in Company
7th Oct 202210:00 amRNSHolding(s) in Company
27th Sep 20221:57 pmRNSHolding(s) in Company
15th Sep 20227:00 amRNSAppointment of Non-Executive Director
8th Sep 20227:00 amRNSDirector/PDMR Shareholding
25th Aug 20227:16 amRNSHalf-year Report
5th Aug 20227:00 amRNSNotice of Results
19th May 20227:00 amRNSDirector/PDMR Shareholding
17th May 202212:00 pmRNSAcquisition
16th May 20227:00 amRNSIssue of Shares
10th May 20223:24 pmRNSResult of AGM
10th May 202212:00 pmRNSTrading Update
6th Apr 20227:00 amRNSNotice of AGM
5th Apr 20227:00 amRNSDirector/PDMR Shareholding
31st Mar 20227:00 amRNSAnnual Report 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.